Johnson & Johnson Preferred Shares: Authorized and Outstanding
The company's filed XBRL preferred stock facts (us-gaap Preferred*), one row per period end, newest first. Values are as filed.
- 2025-12-28: Preferred Stock, Value, Issued $0.00; Preferred Stock, Shares Authorized 2.00M shares.
- 2024-12-29: Preferred Stock, Value, Issued $0.00; Preferred Stock, Shares Authorized 2.00M shares.
- 2023-12-31: Preferred Stock, Value, Issued $0.00; Preferred Stock, Shares Authorized 2.00M shares.
- 2023-01-01: Preferred Stock, Value, Issued $0.00; Preferred Stock, Shares Authorized 2.00M shares.
| Period end | Preferred Stock, Value, Issued | Preferred Stock, Shares Authorized | Preferred Stock, Par or Stated Value Per Share | Preferred Stock, No Par Value | Preferred Stock, Shares Subscribed but Unissued | Preferred Stock, Shares Issued |
|---|---|---|---|---|---|---|
| 2025-12-28 | $0.00 10-K · filed 2026-02-11 | 2.00M shares 10-K · filed 2026-02-11 | ||||
| 2024-12-29 | $0.00 10-K · filed 2026-02-11 | 2.00M shares 10-K · filed 2026-02-11 | ||||
| 2023-12-31 | $0.00 10-K · filed 2025-02-13 | 2.00M shares 10-K · filed 2025-02-13 | ||||
| 2023-01-01 | $0.00 10-K · filed 2024-02-16 | 2.00M shares 10-K · filed 2024-02-16 | ||||
| 2022-01-02 | $0.00 10-K · filed 2023-02-16 | 2.00M shares 10-K · filed 2023-02-16 | ||||
| 2021-01-03 | $0.00 10-K · filed 2022-02-17 | 2.00M shares 10-K · filed 2022-02-17 | ||||
| 2019-12-29 | $0.00 10-K · filed 2021-02-22 | 2.00M shares 10-K · filed 2021-02-22 | $0.00 10-K · filed 2020-02-18 | 0.00 shares 10-K · filed 2020-02-18 | ||
| 2018-12-30 | $0.00 10-K · filed 2020-02-18 | 2.00M shares 10-K · filed 2020-02-18 | $0.00 10-K · filed 2020-02-18 | 0.00 shares 10-K · filed 2020-02-18 | ||
| 2017-12-31 | $0.00 10-K · filed 2019-02-20 | 2.00M shares 10-K · filed 2019-02-20 | $0.00 10-K · filed 2019-02-20 | 0.00 shares 10-K · filed 2019-02-20 | ||
| 2017-01-01 | $0.00 10-K · filed 2018-02-21 | 2.00M shares 10-K · filed 2018-02-21 | $0.00 10-K · filed 2018-02-21 | 0.00 shares 10-K · filed 2018-02-21 | ||
| 2016-01-03 | $0.00 10-K · filed 2017-02-27 | 2.00M shares 10-K · filed 2017-02-27 | $0.00 10-K · filed 2017-02-27 | 0.00 shares 10-K · filed 2017-02-27 | ||
| 2014-12-28 | $0.00 10-K · filed 2016-02-24 | 2.00M shares 10-K · filed 2016-02-24 | $0.00 10-K · filed 2016-02-24 | 0.00 shares 10-K · filed 2016-02-24 | ||
| 2013-12-29 | $0.00 10-K · filed 2015-02-24 | 2.00M shares 10-K · filed 2015-02-24 | $0.00 10-K · filed 2015-02-24 | 0.00 shares 10-K · filed 2015-02-24 | ||
| 2012-12-30 | $0.00 10-K · filed 2014-02-21 | 2.00M shares 10-K · filed 2014-02-21 | $0.00 10-K · filed 2014-02-21 | 0.00 shares 10-K · filed 2014-02-21 | ||
| 2012-01-01 | $0.00 10-K · filed 2013-02-22 | 2.00M shares 10-K · filed 2013-02-22 | 2.00M shares 10-K · filed 2013-02-22 | |||
| 2011-01-02 | $0.00 10-K · filed 2011-02-25 | 2.00M shares 10-K · filed 2012-02-23 | $0.00 10-K · filed 2011-02-25 | |||
| 2010-01-03 | $0.00 10-K · filed 2011-02-25 | 2.00M shares 10-K · filed 2011-02-25 | $0.00 10-K · filed 2011-02-25 | 2.00M shares 10-K · filed 2010-03-01 | ||
| 2009-06-28 | 2.00M shares 10-Q · filed 2009-08-04 | 2.00M shares 10-Q · filed 2009-08-04 | ||||
| 2008-12-28 | $0.00 10-K · filed 2010-03-01 | 2.00M shares 10-K · filed 2010-03-01 | $0.00 10-K · filed 2010-03-01 | 2.00M shares 10-Q · filed 2009-08-04 | 2.00M shares 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |